Kestra Medical Technologies (KMTS) had its "buy" rating reaffirmed by BTIG Research. They now have a $32.00 price target on the stock.
Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
Kestra Medical Technologies (KMTS) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Kestra Medical Technologies (KMTS) had its "buy" rating reaffirmed by BTIG Research. They now have a $32.00 price target on the stock.
Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ... [Yahoo! Finance]